nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroxoline—METAP2—respiratory system—obesity	0.0741	0.161	CbGeAlD
Nitroxoline—METAP2—adrenal cortex—obesity	0.0622	0.135	CbGeAlD
Nitroxoline—METAP2—cardiovascular system—obesity	0.0567	0.124	CbGeAlD
Nitroxoline—METAP2—pituitary gland—obesity	0.0502	0.109	CbGeAlD
Nitroxoline—METAP2—adipose tissue—obesity	0.05	0.109	CbGeAlD
Nitroxoline—METAP2—digestive system—obesity	0.0471	0.103	CbGeAlD
Nitroxoline—METAP2—adrenal gland—obesity	0.0449	0.0977	CbGeAlD
Nitroxoline—METAP2—endocrine gland—obesity	0.0389	0.0847	CbGeAlD
Nitroxoline—METAP2—Diseases associated with visual transduction—PNLIP—obesity	0.0352	0.065	CbGpPWpGaD
Nitroxoline—METAP2—liver—obesity	0.0351	0.0764	CbGeAlD
Nitroxoline—METAP2—Diseases associated with visual transduction—SDC3—obesity	0.0343	0.0635	CbGpPWpGaD
Nitroxoline—METAP2—Diseases associated with visual transduction—RBP4—obesity	0.0227	0.0419	CbGpPWpGaD
Nitroxoline—METAP2—Diseases associated with visual transduction—APOC3—obesity	0.0201	0.0371	CbGpPWpGaD
Nitroxoline—METAP2—Diseases associated with visual transduction—SDC1—obesity	0.0193	0.0356	CbGpPWpGaD
Nitroxoline—METAP2—Diseases associated with visual transduction—AKR1C3—obesity	0.019	0.035	CbGpPWpGaD
Nitroxoline—METAP2—Diseases associated with visual transduction—APOB—obesity	0.0129	0.0239	CbGpPWpGaD
Nitroxoline—METAP2—Diseases associated with visual transduction—LPL—obesity	0.0123	0.0228	CbGpPWpGaD
Nitroxoline—METAP2—Diseases associated with visual transduction—APOE—obesity	0.0103	0.0191	CbGpPWpGaD
Nitroxoline—METAP2—Diseases associated with visual transduction—APOA1—obesity	0.0102	0.0189	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PACS1—obesity	0.00661	0.0122	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TTC21B—obesity	0.00611	0.0113	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MUT—obesity	0.00562	0.0104	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MKS1—obesity	0.00544	0.0101	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—KIF7—obesity	0.00544	0.0101	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CYB5A—obesity	0.00539	0.00997	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ENPP1—obesity	0.00501	0.00927	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRLH—obesity	0.00498	0.00921	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PFKFB3—obesity	0.00471	0.00871	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ACACB—obesity	0.00458	0.00847	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PNLIP—obesity	0.00447	0.00826	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SDC3—obesity	0.00436	0.00806	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HK2—obesity	0.00426	0.00788	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NMB—obesity	0.00413	0.00763	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GHRH—obesity	0.00413	0.00763	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FFAR4—obesity	0.00394	0.00728	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HDAC8—obesity	0.00393	0.00727	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MCHR1—obesity	0.00377	0.00698	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—BRS3—obesity	0.00377	0.00698	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GHSR—obesity	0.00377	0.00698	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PCK1—obesity	0.00357	0.0066	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRLHR—obesity	0.00351	0.00649	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SH2B1—obesity	0.00351	0.00649	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GH1—obesity	0.00351	0.00649	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ACP5—obesity	0.00347	0.00642	CbGpPWpGaD
Nitroxoline—METAP2—Disease—G6PD—obesity	0.00338	0.00626	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HK1—obesity	0.00334	0.00618	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—APLN—obesity	0.0033	0.0061	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PYY—obesity	0.0033	0.0061	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PNLIP—obesity	0.00313	0.00578	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SDC3—obesity	0.00305	0.00564	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HCRT—obesity	0.00298	0.00552	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NMU—obesity	0.00298	0.00552	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PMCH—obesity	0.00298	0.00552	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NPY5R—obesity	0.00298	0.00552	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RBP4—obesity	0.00288	0.00532	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NPY2R—obesity	0.00286	0.00529	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MC4R—obesity	0.00286	0.00529	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MC3R—obesity	0.00286	0.00529	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NPY1R—obesity	0.00286	0.00529	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PPY—obesity	0.0028	0.00519	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GIP—obesity	0.00275	0.00509	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HDAC8—obesity	0.00275	0.00509	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRKCH—obesity	0.00275	0.00509	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PRKAR2B—obesity	0.00273	0.00504	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CST3—obesity	0.00273	0.00504	CbGpPWpGaD
Nitroxoline—METAP2—Disease—DCN—obesity	0.00271	0.005	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NCF2—obesity	0.00263	0.00487	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—LEPR—obesity	0.00262	0.00484	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NAMPT—obesity	0.00258	0.00477	CbGpPWpGaD
Nitroxoline—METAP2—Disease—GCK—obesity	0.00256	0.00474	CbGpPWpGaD
Nitroxoline—METAP2—Disease—APOC3—obesity	0.00255	0.00471	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IAPP—obesity	0.00255	0.00471	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SDC1—obesity	0.00245	0.00452	CbGpPWpGaD
Nitroxoline—METAP2—Disease—AKR1C3—obesity	0.00241	0.00445	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ADRB3—obesity	0.00234	0.00433	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GAL—obesity	0.00229	0.00423	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—C5AR1—obesity	0.00226	0.00418	CbGpPWpGaD
Nitroxoline—METAP2—Disease—GOT2—obesity	0.00224	0.00414	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FASN—obesity	0.00219	0.00405	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PARP1—obesity	0.00218	0.00403	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRKG1—obesity	0.00207	0.00382	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCK—obesity	0.00207	0.00382	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NOS1—obesity	0.00205	0.00379	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TCF7L2—obesity	0.00203	0.00375	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RBP4—obesity	0.00202	0.00373	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GLP1R—obesity	0.00202	0.00373	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SLC2A4—obesity	0.00199	0.00369	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCKAR—obesity	0.00198	0.00367	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HRH3—obesity	0.00198	0.00367	CbGpPWpGaD
Nitroxoline—METAP2—Disease—GOT1—obesity	0.00193	0.00357	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRKAR2B—obesity	0.00191	0.00353	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PRL—obesity	0.0019	0.00352	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NCF2—obesity	0.00184	0.00341	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FOXO3—obesity	0.00181	0.00335	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NPY—obesity	0.0018	0.00332	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IAPP—obesity	0.00178	0.0033	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—APOC3—obesity	0.00178	0.0033	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CRH—obesity	0.00173	0.0032	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HTR1B—obesity	0.00173	0.0032	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SDC1—obesity	0.00171	0.00317	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AKR1C3—obesity	0.00169	0.00312	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NPS—obesity	0.00164	0.00304	CbGpPWpGaD
Nitroxoline—METAP2—Disease—APOB—obesity	0.00164	0.00303	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—DRD1—obesity	0.00161	0.00298	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HTR2C—obesity	0.00161	0.00298	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NTRK2—obesity	0.00157	0.0029	CbGpPWpGaD
Nitroxoline—METAP2—Disease—LPL—obesity	0.00157	0.00289	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ADRB1—obesity	0.00156	0.00289	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FOXO1—obesity	0.00155	0.00287	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PARP1—obesity	0.00153	0.00282	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GHRL—obesity	0.00153	0.00282	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—DRD4—obesity	0.00151	0.0028	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CNR1—obesity	0.00145	0.00267	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PRKCD—obesity	0.00144	0.00267	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TCF7L2—obesity	0.00142	0.00263	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—DRD2—obesity	0.00141	0.00261	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MTHFR—obesity	0.00141	0.00261	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PTPN1—obesity	0.0014	0.00258	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GCG—obesity	0.0014	0.00258	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IRS2—obesity	0.00134	0.00248	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRL—obesity	0.00133	0.00246	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—STK11—obesity	0.00131	0.00243	CbGpPWpGaD
Nitroxoline—METAP2—Disease—APOE—obesity	0.00131	0.00243	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CAV1—obesity	0.0013	0.0024	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PLG—obesity	0.0013	0.0024	CbGpPWpGaD
Nitroxoline—METAP2—Disease—APOA1—obesity	0.0013	0.0024	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FOXO3—obesity	0.00127	0.00234	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ADRB2—obesity	0.00126	0.00234	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SOCS1—obesity	0.00124	0.0023	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SOCS3—obesity	0.00123	0.00227	CbGpPWpGaD
Nitroxoline—METAP2—Disease—BAD—obesity	0.00122	0.00226	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GNB3—obesity	0.0012	0.00223	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IGF2—obesity	0.00118	0.00219	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GNAS—obesity	0.00117	0.00217	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IRS1—obesity	0.00117	0.00216	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—APOB—obesity	0.00115	0.00212	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCL5—obesity	0.00112	0.00207	CbGpPWpGaD
Nitroxoline—METAP2—Disease—INS—obesity	0.00112	0.00207	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—LPL—obesity	0.0011	0.00203	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FOXO1—obesity	0.00109	0.00201	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RPS6KB1—obesity	0.00109	0.00201	CbGpPWpGaD
Nitroxoline—METAP2—Disease—AKT2—obesity	0.00108	0.002	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PIK3CD—obesity	0.00104	0.00192	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SERPINE1—obesity	0.00103	0.0019	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRKCD—obesity	0.00101	0.00187	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TYK2—obesity	0.001	0.00185	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RHOA—obesity	0.000993	0.00184	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HTR2A—obesity	0.000988	0.00183	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—C3—obesity	0.000987	0.00182	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PIK3R1—obesity	0.000983	0.00182	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NOS3—obesity	0.000983	0.00182	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IRS2—obesity	0.000939	0.00174	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AGT—obesity	0.000938	0.00173	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—APOE—obesity	0.000919	0.0017	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—LEP—obesity	0.000919	0.0017	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CAV1—obesity	0.00091	0.00168	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—APOA1—obesity	0.000908	0.00168	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MTOR—obesity	0.000907	0.00168	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PIK3CB—obesity	0.000907	0.00168	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PTGS2—obesity	0.000899	0.00166	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ESR1—obesity	0.000877	0.00162	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—F2—obesity	0.000866	0.0016	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRKCB—obesity	0.000866	0.0016	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—BAD—obesity	0.000856	0.00158	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CG—obesity	0.000829	0.00153	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IRS1—obesity	0.00082	0.00152	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—POMC—obesity	0.000789	0.00146	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—INS—obesity	0.000785	0.00145	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCL2—obesity	0.000772	0.00143	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IGF1—obesity	0.000759	0.0014	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AKT2—obesity	0.000759	0.0014	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CD—obesity	0.000729	0.00135	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SERPINE1—obesity	0.000721	0.00133	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TYK2—obesity	0.000701	0.0013	CbGpPWpGaD
Nitroxoline—METAP2—Disease—STAT3—obesity	0.000701	0.0013	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RHOA—obesity	0.000695	0.00129	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3R1—obesity	0.000688	0.00127	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NOS3—obesity	0.000688	0.00127	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MYC—obesity	0.000651	0.0012	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TGFB1—obesity	0.00065	0.0012	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CB—obesity	0.000635	0.00117	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MTOR—obesity	0.000635	0.00117	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PIK3CA—obesity	0.000553	0.00102	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MMP9—obesity	0.000552	0.00102	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MAPK8—obesity	0.000537	0.000993	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—STAT3—obesity	0.000491	0.000908	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IL6—obesity	0.00049	0.000906	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MYC—obesity	0.000456	0.000844	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TGFB1—obesity	0.000455	0.000842	CbGpPWpGaD
Nitroxoline—METAP2—Disease—AKT1—obesity	0.000452	0.000836	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CA—obesity	0.000387	0.000716	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IL6—obesity	0.000343	0.000634	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AKT1—obesity	0.000316	0.000585	CbGpPWpGaD
